1. Home
  2. RDHL vs AYRO Comparison

RDHL vs AYRO Comparison

Compare RDHL & AYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • AYRO
  • Stock Information
  • Founded
  • RDHL 2009
  • AYRO 2017
  • Country
  • RDHL Israel
  • AYRO United States
  • Employees
  • RDHL N/A
  • AYRO N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • AYRO Telecommunications Equipment
  • Sector
  • RDHL Health Care
  • AYRO Consumer Discretionary
  • Exchange
  • RDHL Nasdaq
  • AYRO Nasdaq
  • Market Cap
  • RDHL 3.9M
  • AYRO 3.7M
  • IPO Year
  • RDHL N/A
  • AYRO N/A
  • Fundamental
  • Price
  • RDHL $1.34
  • AYRO $7.08
  • Analyst Decision
  • RDHL
  • AYRO
  • Analyst Count
  • RDHL 0
  • AYRO 0
  • Target Price
  • RDHL N/A
  • AYRO N/A
  • AVG Volume (30 Days)
  • RDHL 142.3K
  • AYRO 77.1K
  • Earning Date
  • RDHL 09-02-2025
  • AYRO 08-14-2025
  • Dividend Yield
  • RDHL N/A
  • AYRO N/A
  • EPS Growth
  • RDHL N/A
  • AYRO N/A
  • EPS
  • RDHL N/A
  • AYRO N/A
  • Revenue
  • RDHL $8,042,999.00
  • AYRO $5,426.00
  • Revenue This Year
  • RDHL $381.91
  • AYRO N/A
  • Revenue Next Year
  • RDHL N/A
  • AYRO N/A
  • P/E Ratio
  • RDHL N/A
  • AYRO N/A
  • Revenue Growth
  • RDHL 23.17
  • AYRO N/A
  • 52 Week Low
  • RDHL $1.06
  • AYRO $5.17
  • 52 Week High
  • RDHL $12.50
  • AYRO $15.28
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 42.30
  • AYRO 54.00
  • Support Level
  • RDHL $1.31
  • AYRO $5.73
  • Resistance Level
  • RDHL $1.48
  • AYRO $7.03
  • Average True Range (ATR)
  • RDHL 0.09
  • AYRO 0.67
  • MACD
  • RDHL 0.03
  • AYRO -0.01
  • Stochastic Oscillator
  • RDHL 65.48
  • AYRO 61.14

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About AYRO AYRO Inc.

AYRO Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.

Share on Social Networks: